# A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

> **NCT06766357** · PHASE3 · RECRUITING · sponsor: **Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.** · enrollment: 360 (estimated)

## Conditions studied

- Moderate to Severe Dry Eye

## Interventions

- **DRUG:** Cyclosporine ophthalmic gel
- **DRUG:** Cyclosporine ophthalmic gel vehicle

## Key facts

- **NCT ID:** NCT06766357
- **Lead sponsor:** Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-03
- **Primary completion:** 2026-02
- **Final completion:** 2026-06
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06766357

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06766357, "A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06766357. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*